About Us | Contact Us |        
LOGIN OR REGISTER
Course Library

Avoiding Missed Opportunities in PsA: Early Recognition, Optimal Therapy, and Coordination of Care

Rheumatology
Curriculum:
Avoiding Missed Opportunities in PsA: Early Recognition, Optimal Therapy, and Coordination of Care
Credits:
1 AMA PRA Category 1 Credit(s) ™
Launch Date:
September 15, 2015
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Physicians, Physician Assistants, Nurse Practitioners

Relevant Terms:

Psoriatic arthritis

M. Elaine Husni, MD, MPH

M. Elaine Husni, MD, MPH
Director, Arthritis & Musculoskeletal Treatment Center
Cleveland Clinic
Cleveland, OH

M. Elaine Husni, MD, MPH, is vice chair of rheumatology and director of the Arthritis and Musculoskeletal Center. She is a staff physician in the Orthopaedic & Rheumatologic Institute at Cleveland Clinic. Dr. Husni is also an assistant professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
 
Dr. Husni joined the Clinic in 2005 following a faculty appointment at Harvard Medical School, Brigham and Women's Hospital. She completed her internship and residency at the Beth Israel Deaconess Hospital at Harvard Medical School, and she trained in rheumatology at the Brigham and Women's Hospital at Harvard Medical School. Dr. Husni received her MD and MPH degrees at Boston University School of Medicine.

Dr. Husni's research interests include examining health outcomes of patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and osteoarthritis, specifically in the area of cardiovascular disease. She is the current recipient of the Clinical Investigator Award by the American College of Rheumatology for this work. She is involved in a number of rheumatology clinical trials at Cleveland Clinic and serves on the Executive Committee of the PRECISION trial.

She also has a research focus on orthopaedic outcomes with a specific research interest in the use of clinical pathways in patients undergoing total joint arthroplasty. She is a past recipient of the Physician Scientist Development Award by the American College of Rheumatology for this research. She is currently director of Musculoskeletal Outcomes research and the fellow's research committee for the Rheumatology Department. She is currently on the medical and scientific committee for the Arthritis Foundation of the Northeastern Ohio Chapter. She is also on the medical board of the Arthritis Foundation and the National Psoriasis Foundation. Dr. Husni has had the opportunity to mentor both rheumatology and orthopedic research trainees and this has been one of her most rewarding experiences.

Andrea L. Neimann, MD

Andrea L. Neimann, MD
Director, Dermatology Clinical Studies Unit
Assistant Professor of Dermatology
New York University School of Medicine
NYU Langone Medical Center
New York, New York

Andrea L. Neimann, MD, is the director of the Dermatology Clinical Studies Unit and assistant professor of dermatology at New York University School of Medicine, NYU Langone Medical Center. She received her MD from the University of the Witwatersrand in Johannesburg, South Africa, and her MSCE certification in epidemiology from the University of Pennsylvania in Philadelphia. She completed her residency at the Albert Einstein College of Medicine in New York City. Dr. Neimann has co-authored dozens of articles, book chapters, abstracts, letters, and posters. She is a member of the American Academy of Dermatology and Fellow of the American College of Physicians.
 
 

Jose U. Scher, MD

Jose U. Scher, MD
Assistant Professor Medicine (Rheumatology)
New York University School of Medicine
New York, NY

Jose U. Scher, MD, is an assistant professor in the Department of Medicine at New York University (NYU) Langone Medical Center. He serves as director of the Arthritis Clinic at NYU-Hospital for Joint Diseases, the Psoriatic Arthritis Center at NYU Langone Medical Center, and the Microbiome Center for Rheumatology and Autoimmunity at NYU School of Medicine. As the director of the Psoriatic Arthritis Center, Dr. Scher oversees patient care, education, and translational research initiatives in psoriatic arthritis. His main area of research is related to the role of the human microbiome in autoimmune and rheumatic disease, specifically in psoriasis, psoriatic arthritis, and rheumatoid arthritis.
1. Differentiate between psoriatic arthritis (PsA) and other arthritides to ensure early and accurate diagnosis of PsA
2. Appropriately incorporate the various disease modifying agents into the management of patients with PsA taking into consideration patient comorbidities
3. Utilize effective communication and collaboration techniques to foster clinical care coordination among care team members
4. Integrate shared decision-making techniques to improve patients' understanding of the risks and benefits of their treatments and to allow them to participate in healthcare decisions

PHYSICIAN CONTINUING MEDICAL EDUCATION
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
 
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
 
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
  • M. Elaine Husni, MD, MPH, has affiliations with AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Eli Lilly and Company, Genentech, Novartis, Janssen, Pfizer (Consulting).
  • Andrea L. Neimann, MD, has affiliations with Abbott Laboratories, AbbVie (Stockholder).
  • Jose U. Scher, MD, has affiliations with AbbVie, Janssen, Novartis (Consulting).
RMEI, LLC
  • Boris Rozenfeld, MD, has no affiliations with commercial interests to disclose.
  • Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
  • Amy Reeve, has no affiliations with commercial interests to disclose.
Postgraduate Institute for Medicine
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, MSN, RN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
 
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
 
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Estimated time to complete: 1.0 hour
Medium: Internet

FEE INFORMATION
There is no fee for this educational activity.

STATEMENT OF SUPPORT
This activity is supported by an independent educational grant from AbbVie Inc.

HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive up to 1.0 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
 
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the post-test and activity evaluation.
Physicians who successfully complete the post-test and evaluation will receive CME credit. Users must score 70% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.		 Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above



 

Schedule an event with a Standardized Patient
×